Elsevier

Journal of Hepatology

Volume 42, Issue 3, March 2005, Pages 302-308
Journal of Hepatology

From Bench to Bedside
New insight on hepatitis B virus persistence from the study of intrahepatic viral cccDNA

https://doi.org/10.1016/j.jhep.2004.12.015Get rights and content

Introduction

Chronic hepatitis B virus (HBV) infection remains a major health problem affecting approximately 400 million people worldwide. Although HBV replication is only mildly cytopathic, cellular immune responses directed against the virus can produce substantial liver damage and result in chronic hepatitis, cirrhosis, and hepatocellular carcinoma [1], [2]. Chronic hepatitis B (CH-B) encompasses a broad spectrum of disease and can be divided into several phases of natural history which are distinguishable by serological and virological markers. One goal of antiviral therapy is to accelerate patients with chronic active disease into later natural history phases wherein viral replication abates and the incidence of serious liver disease is significantly reduced. With the knowledge gained from the molecular biology of HBV infection, it was shown that HBV covalently closed circular (ccc) DNA plays a key role in viral persistence, viral reactivation after treatment withdrawal, and drug resistance.

Section snippets

What is cccDNA?

Chronic infection is believed to be maintained by a replicative form of HBV DNA termed covalently closed circular (ccc) DNA (Fig. 1). Formation of cccDNA from incoming virions implies the trafficking of nucleocapsids to the nucleus, the entry of relaxed circular DNA in the nucleus, the completion of plus strand DNA synthesis, the removal of the polymerase primer for minus strand DNA synthesis and of the RNA primer for plus strand DNA synthesis, the ligation of both DNA strand extremities, and

Is cccDNA stable?

The importance of cccDNA in HBV persistence at the level of a single cell has been demonstrated in tissue culture experiments. Using nucleoside analogs to block HBV DNA synthesis and recycling of cccDNA by the trafficking of nucleocapsids to the nucleus, it was possible to analyze the half-life of cccDNA in non-dividing cells. Depending on experimental conditions, i.e. using primary duck or woodchuck hepatocytes, or in hepatoma cell lines, a range of results were obtained. Some studies showed

Detection of intrahepatic cccDNA

Despite the crucial role of cccDNA during persistent infection and the importance of understanding clearance mechanisms, few data have been collected from patients [26], [27]. Indeed, our current understanding of cccDNA has been obtained primarily through studies of the woodchuck and duck hepatitis B virus models [8], [9], [28], [29]. Historical obstacles to the study of HBV cccDNA have been (1) the requirement for liver biopsies, which are difficult to collect, especially from patients in

Perspectives for antiviral therapy

The detection of cccDNA in the liver of infected patients may represent an important marker to monitor antiviral therapy. As assays for its quantification are not used routinely, the quantification of cccDNA decline during antiviral therapy may represent an important treatment endpoint in the setting of clinical trials using new antiviral drugs or new combinations. Information gained from such studies may help to provide recommendation for the duration of antiviral therapy and new insight in

Acknowledgements

This work was supported by funding from the European Community (HepBvar project contract QLRT2001-00977; and viRgil network contract LSHM-CT-2004-503359).

First page preview

First page preview
Click to open first page preview

References (54)

  • J. Kock et al.

    Hepatitis B virus nucleic acids associated with human peripheral blood mononuclear cells do not originate from replicating virus

    Hepatology

    (1996)
  • B. Werle-Lapostolle et al.

    Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy

    Gastroenterology

    (2004)
  • C. Grandjacques et al.

    Rapid detection of genotypes and mutations in the pre-core promoter and the pre-core region of hepatitis B virus genome: correlation with viral persistence and disease severity

    J Hepatol

    (2000)
  • G.L. Davis et al.

    Spontaneous reactivation of chronic hepatitis B virus infection

    Gastroenterology.

    (1984)
  • A.S. Lok et al.

    Acute exacerbations in Chinese patients with chronic hepatitis B virus (HBV) infection. Incidence, predisposing factors and etiology

    J Hepatol

    (1990)
  • S.R. Lewin et al.

    Analysis of hepatitis B viral load decline under potent therapy: Complex decay profiles observed

    Hepatology

    (2001)
  • C. Boni et al.

    Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy

    Hepatology

    (2001)
  • C. Borel et al.

    Initial amplification of duck hepatitis B virus covalently closed circular DNA after in vitro infection of embryonic duck hepatocytes is increased by cell cycle progression

    Hepatology

    (2001)
  • M. Maynard et al.

    Sustained HBs seroconversion during lamivudine and adefovir dipivoxil combination therapy for lamivudine failure

    J Hepatol

    (2005)
  • W.M. Lee

    Hepatitis B virus infection

    N Engl J Med

    (1997)
  • D. Ganem et al.

    Hepatitis B virus infection—natural history and clinical consequences

    N Engl J Med

    (2004)
  • C. Seeger et al.

    Hepatitis B virus biology

    Microbiol Mol Biol Rev

    (2000)
  • J. Newbold et al.

    The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minichromosomes

    J Virol

    (1995)
  • G. Moraleda et al.

    Lack of effect of antiviral therapy in nondividing hepatocyte cultures on the closed circular DNA of woodchuck hepatitis virus

    J Virol

    (1997)
  • I. Fourel et al.

    Evidence that hepatocyte turnover is required for rapid clearance of Duck Hepatitis B Virus during antiviral therapy of chronically infected ducks

    J Virol

    (1994)
  • J.T. Guo et al.

    Apoptosis and regeneration of hepatocytes during recovery from transient hepadnavirus infections [In Process Citation]

    J Virol

    (2000)
  • R. Thimme et al.

    CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection

    J Virol

    (2003)
  • Cited by (0)

    View full text